SOBI:STO
Swedish Orphan Biovitrum AB (publ)
437,20Â SEK
arrow_upward
+0,18%(+0,80) 1d
19 d’oct., 17:29:37 GMT+2 · SEK
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a SOBI...
Obre
437,60Â SEK
Alt
440,00Â SEK
Baix
431,00Â SEK
Capitalització borsà ria
156,36Â kM
Volum mitjÃ
259,17Â k
Volum
194,80Â k
RÃ tio preu-benefici
116,77
Alt 52 setmanes
487,00Â SEK
Baix 52 setmanes
304,80Â SEK
BPA
3,74Â SEK
Accions en circulació
357,64Â M
Nombre d'empleats
2Â k
Obre
437,60Â SEK
Alt
440,00Â SEK
Baix
431,00Â SEK
Capitalització borsà ria
156,36Â kM
Volum mitjÃ
259,17Â k
Volum
194,80Â k
RÃ tio preu-benefici
116,77
Alt 52 setmanes
487,00Â SEK
Baix 52 setmanes
304,80Â SEK
BPA
3,74Â SEK
Accions en circulació
357,64Â M
Nombre d'empleats
2Â k
NotÃcies
De fonts web i partners de notÃcies
CBS News
·
fa 1 hora
Susan G. Komen Foundation rings opening bell at New York Stock Exchange
Stocktwits
·
fa 33 minuts
Nasdaq 100 Sees Best Day In Nearly A Month As AI Rout Cools — AMZN, BE, CRWV, AAPL, PLTR In Focus
FinancialContent
·
fa 1 hora
Zions Bancorporation (NASDAQ:ZION) Beats Q3 2026 EPS Estimates
Reuters
·
fa 6 minuts
Nasdaq climbs as chip and AI-linked stocks bounce back
Perfil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Sobre Swedish Orphan Biovitrum AB (publ)